Stocks · News reference
Regulatory approval enables commercialization of QT Imaging's technology in Israel and supports expansion of clinical research collaborationsQT Imaging Holdings, Inc.(NASDAQ:QTI) ("QT Imaging" or the
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
QT Imaging Holdings (NASDAQ:QTI) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.22) by 13.64 percent. This is a 54.76 percent increase over losses of $(0.42) per share
QT Imaging Holdings (NASDAQ:QTI) affirms FY2026 sales outlook from $39.000 million to $39.000 million vs $39.200 million estimate.
QT Imaging Holdings (NASDAQ:QTI) reported quarterly losses of $(0.75) per share which missed the analyst consensus estimate of $(0.22) by 240.91 percent. This is a 78.57 percent decrease over losses of $(0.42) per share